HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
批准号:
10523733
负责人:
MALINI RAGHAVAN
金额:
$18.83万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2024-05-31
关键词:
2019-nCoVAddressAllelesAntigensBindingBinding SitesBiologyBloodBlood donorCD8-Positive T-LymphocytesCOVID-19COVID-19 vaccinationCOVID-19 vaccineCell surfaceCellsCellular AssayCommunicable DiseasesCytotoxic T-LymphocytesDataDependenceDiseaseDisease OutcomeEpitopesEthnic groupGenesGenotypeHIVHLA AntigensHistocompatibility Antigens Class IHumanImmuneImmune responseImmunityIndividualInfectionInfectious AgentKnowledgeLeadLightMajor Histocompatibility ComplexMalignant NeoplasmsMass Spectrum AnalysisMeasurableMeasuresMediator of activation proteinMolecularMutatePeptidesPersonsPopulationPrevalencePropertyProteinsProteomeRaceResolutionSARS-CoV-2 infectionSARS-CoV-2 spike proteinSpecificityStainsStructureT cell responseT-Cell ActivationT-LymphocyteTestingTranslatingVaccinatedVaccinesVariantViralViral CancerVirusVirus Diseasesbasebeta-2 Microglobulincancer cellknowledge of resultspathogenpeptide Ipredictive toolsprotein aminoacid sequencetapasinvaccine efficacy
中文摘要
CD8+T细胞在主要组织相容性复合体I类(MHC-1)背景下识别短肽抗原
I)蛋白质。人类白细胞抗原(HLAA)、HLAB和HLAC三组基因编码
人类MHC-I(β-I)蛋白的重链,也包含轻链(HLA2-微球蛋白)和
多肽。HLAA、HLAB和HLAC基因具有高度的多态性。在细胞中,个别的人类白细胞抗原-I同种异型可以
可与许多来源于细胞内蛋白的多肽结合。细胞感染诱导特异性结合
病原体衍生的多肽,可触发CD8+T细胞识别和免疫。近期质量
光谱(MS)研究已经确定了数千个与人类白细胞抗原-I结合的多肽的序列
同种异型,个别的多肽。对这些肽序列的检查导致了变量假说
人类白细胞抗原-I同种异型之间的多肽谱系大小及其导致的CD8+T细胞反应广度的差异
到感染SARS-Cov2和接种新冠肺炎疫苗。为了解决这一假设,在拟议的研究中,
定量高分辨质谱学(MS)将被用来测量自身多肽的差异
选定的人类白细胞抗原-B同种异型的谱系大小。曲目大小变化背后的因素将是
检查过了。此外,诱导CD8+T细胞激活的SARS-CoV-2尖峰表位的广度将是
使用已接种COVID-19疫苗的精选HLA型献血者的血液进行测量,
检测在人类白细胞抗原-I同种异型之间表位宽度变化的流行率。总而言之,这些研究
解决不同的人类白细胞抗原-I型多肽多样性的流行和后果,重点是免疫
由新冠肺炎疫苗诱导。这些研究所产生的知识将为人类白细胞抗原的关键方面提供信息。
I生物学和疫苗诱导的免疫力。
英文摘要
CD8+ T cells recognize short peptide antigens in the context of major histocompatibility complex class I (MHC-
I) proteins. Three sets of genes, the human leukocyte antigens (HLA) HLA-A, HLA-B and HLA-C encode the
heavy chains of human MHC-I (HLA-I) proteins, which also contain a light chain (β2-microglobulin) and a
peptide. The HLA-A, HLA-B and HLA-C genes are highly polymorphic. In cells, individual HLA-I allotypes can
bind to many peptides derived from intracellular proteins. Cell infection induces the binding of specific
pathogen-derived peptides, which can trigger CD8+ T cell recognition and immunity. Recent mass
spectrometric (MS) studies have identified the sequences of thousands of peptides that bind to HLA-I
allotypes, the individual peptidomes. Inspections of these peptide sequences lead to the hypothesis of variable
peptide repertoire sizes among HLA-I allotypes and resulting variations in the breadth of CD8+ T cell responses
to SARS-Cov2 infection and COVID-19 vaccination. To address this hypothesis, in the proposed studies,
quantitative high resolution mass spectrometry (MS) will be used to measure differences in self-peptide
repertoire sizes for selected HLA-B allotypes. Factors that underlie variations in repertoire sizes will be
examined. Additionally, the breadth of SARS-CoV-2 Spike epitopes that induce CD8+ T cell activation will be
measured using blood from select HLA genotyped blood donors who have been vaccinated against COVID-19,
examining the prevalence of epitope breadth variations among HLA-I allotypes. Taken together, these studies
address the prevalence and consequences of variable HLA-I peptidome diversities, with a focus on immunity
induced by COVID-19 vaccines. The knowledge resulting from these studies will inform on key aspects of HLA-
I biology and vaccine-indued immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
-
批准号:10632096
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2022
-
负责人:MALINI RAGHAVAN
-
依托单位:
Peptide Repertoires of HLA class I molecules
-
批准号:9316821
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2017
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin-mediated protein folding in health and disease
-
批准号:10599361
-
项目类别:
-
资助金额:$45.13万
-
财政年份:2016
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin-mediated protein folding in health and disease
-
批准号:10362228
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2016
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin-mediated protein folding in health and disease
-
批准号:9095546
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin-mediated protein folding in health and disease
-
批准号:9238654
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:MALINI RAGHAVAN
-
依托单位:
Interactions and mechanisms of function of the TAP complex
-
批准号:7881378
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2009
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7881344
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2009
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7924278
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2009
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7213582
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2007
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7775065
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2007
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7586139
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2007
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7575527
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2007
-
负责人:MALINI RAGHAVAN
-
依托单位:
Calreticulin's functions in the adaptive immune response
-
批准号:7384495
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:MALINI RAGHAVAN
-
依托单位:
INTERACTIONS & MECHANISMS OF FUNCTION OF THE TAP COMPLEX
-
批准号:6341725
-
项目类别:
-
资助金额:$17.24万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
Interactions & mechanisms of function of the TAP complex
-
批准号:6859387
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
Influences of HLA Class I Polymorphisms on immune responses
-
批准号:8878984
-
项目类别:
-
资助金额:$43.14万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
Interactions and mechanisms of function of the TAP complex
-
批准号:8006401
-
项目类别:
-
资助金额:$37.85万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
Influences of HLA Class I Polymorphisms on Immune Responses
-
批准号:10326865
-
项目类别:
-
资助金额:$46.52万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
Interactions & mechanisms of function of the TAP complex
-
批准号:7032349
-
项目类别:
-
资助金额:$29.51万
-
财政年份:1999
-
负责人:MALINI RAGHAVAN
-
依托单位:
海外基金